Physician profile
David E Rhodes
NPI 1518968353
$1,569.68
in general payments reported to CMS, 2019-2025
18 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $179 · 2022: $280 · 2023: $194 · 2024: $298 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $369.68 | 2019-2024 | Mounjaro, Zepbound |
| Amgen INC. | $294.56 | 2019-2025 | Tavneos, Evenity, Prolia |
| Novo Nordisk INC | $169.17 | 2019-2022 | |
| Glaxosmithkline, LLC. | $156.07 | 2019-2024 | Bexsero, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $127.06 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $84.53 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.02 | 2023-2025 | Xifaxan |
| Allergan, INC. | $45.18 | 2020 | |
| Ibsa Pharma INC. | $44.67 | 2024-2025 | Licart, Tirosint, Flector |
| Merck Sharp & Dohme LLC | $40.83 | 2019-2020 | |
| Dynavax Technologies Corporation | $39.07 | 2019-2020 | |
| Sanofi Pasteur INC. | $34.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.86 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.00 | 2022 | |
| Abbvie INC. | $18.87 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.63 | 2024 | Nexletol |
| Phathom Pharmaceuticals, INC. | $13.53 | 2024 | Voquezna |
| Linus Health, INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rhodes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.